| Medical and Health Sciences | 2021-2025 | 47 | CA 3 | 99.99 |
| Psychology and Behavioral Sciences | 2021-2025 | 56 | CA 5 | 99.87 |
| Biological Sciences | 2021-2025 | 423 | CA 12 | 99.55 |
| Social Sciences, Law and Public Affairs | 2021-2025 | 829 | CA 33 | 99.17 |
| Mathematics and Statistics | 2021-2025 | 668 | CA 25 | 93.88 |
| Epidemiology | Lifetime | 965 | CA 46 | 98.70 |
| Health | Lifetime | 342 | CA 17 | 97.84 |
| Orthopedics and Sports Medicine | Lifetime | 426 | CA 22 | 96.33 |
| Modeling and Simulation | Lifetime | 318 | CA 9 | 92.68 |
| Complementary and Alternative Medicine | Lifetime | 813 | CA 44 | 91.44 |
| Applied Psychology | Lifetime | 625 | CA 31 | 89.53 |
| Health Informatics | Lifetime | 90 | CA 4 | 87.82 |
| Dermatology | Lifetime | 899 | CA 20 | 88.06 |
| Virology | Lifetime | 581 | CA 14 | 76.72 |
| Medical Physiology | 2021-2025 | 69 | CA 3 | 99.10 |
| General Health Professions | 2021-2025 | 139 | CA 14 | 99.02 |
| Epidemiology | 2021-2025 | 167 | CA 5 | 98.93 |
| Cognitive Psychology | 2021-2025 | 67 | CA 3 | 98.69 |
| Sociology and Political Science | 2021-2025 | 495 | CA 14 | 98.72 |
| Public, Environmental and Occupational Health | 2021-2025 | 190 | CA 13 | 98.38 |
| Orthopedics and Sports Medicine | 2021-2025 | 43 | CA 4 | 98.63 |
| Social Psychology | 2021-2025 | 156 | CA 12 | 98.25 |
| Virology | 2021-2025 | 8 | CA 1 | 96.95 |
| Clinical Psychology | 2021-2025 | 258 | CA 19 | 98.06 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 326 | CA 19 | 96.81 |
| Health Informatics | 2021-2025 | 67 | CA 4 | 95.42 |
| Health | 2021-2025 | 166 | CA 9 | 95.39 |
| Complementary and Alternative Medicine | 2021-2025 | 130 | CA 7 | 94.39 |
| Infectious Diseases | 2021-2025 | 288 | CA 6 | 94.77 |
| Modeling and Simulation | 2021-2025 | 122 | CA 2 | 94.80 |
| Psychiatry and Mental health | 2021-2025 | 360 | CA 18 | 90.73 |
| Developmental and Educational Psychology | 2021-2025 | 407 | CA 24 | 89.63 |
| Clinical Neurology | 2021-2025 | 359 | CA 14 | 88.74 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 426 | CA 16 | 88.26 |
| Finance and Banking | 2021-2025 | 273 | CA 9 | 85.03 |
| Genetics | 2021-2025 | 579 | CA 30 | 83.55 |
| Hematology | 2021-2025 | 407 | CA 22 | 72.15 |
| Data-Driven Disease Surveillance | Lifetime | 12 | CA 1 | 99.09 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 192 | CA 3 | 99.18 |
| COVID-19 and Mental Health | Lifetime | 126 | CA 7 | 98.58 |
| COVID-19 Clinical Research Studies | Lifetime | 293 | CA 6 | 98.70 |
| Dietary Effects on Health | Lifetime | 37 | CA 3 | 98.70 |
| Vaccine Coverage and Hesitancy | Lifetime | 124 | CA 9 | 98.85 |
| COVID-19 epidemiological studies | Lifetime | 134 | CA 6 | 98.77 |
| Long-Term Effects of COVID-19 | Lifetime | 262 | CA 9 | 97.71 |
| COVID-19 and healthcare impacts | Lifetime | 327 | CA 12 | 95.75 |
| Sleep and related disorders | Lifetime | 386 | CA 22 | 97.34 |
| Sports Performance and Training | Lifetime | 615 | CA 39 | 98.03 |
| Sports injuries and prevention | Lifetime | 715 | CA 32 | 97.82 |
| Poxvirus research and outbreaks | Lifetime | 177 | CA 7 | 96.18 |
| Artificial Intelligence in Healthcare and Education | Lifetime | 275 | CA 8 | 93.86 |
| Bacillus and Francisella bacterial research | Lifetime | 316 | CA 10 | 95.12 |
| Influenza Virus Research Studies | Lifetime | 938 | CA 33 | 96.33 |
| COVID-19 Pandemic Impacts | Lifetime | 329 | CA 7 | 93.41 |
| Digital Mental Health Interventions | Lifetime | 422 | CA 13 | 95.36 |
| Misinformation and Its Impacts | Lifetime | 355 | CA 10 | 94.68 |
| Impact of Technology on Adolescents | Lifetime | 797 | CA 34 | 94.65 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 897 | CA 30 | 93.86 |
| Zoonotic diseases and public health | Lifetime | 735 | CA 29 | 91.83 |
| COVID-19 diagnosis using AI | Lifetime | 764 | CA 22 | 89.77 |
| Advanced Biosensing Techniques and Applications | Lifetime | 891 | CA 24 | 91.15 |
| Optimism, Hope, and Well-being | Lifetime | 506 | CA 25 | 90.73 |
| History of Medicine Studies | Lifetime | 251 | CA 3 | 88.73 |
| Sleep and Work-Related Fatigue | Lifetime | 930 | CA 36 | 88.56 |
| Genetics and Physical Performance | Lifetime | 745 | CA 32 | 81.20 |
| Sex and Gender in Healthcare | Lifetime | 671 | CA 55 | 74.94 |
| Dermatological and COVID-19 studies | Lifetime | 954 | CA 21 | 72.11 |
| Hidradenitis Suppurativa and Treatments | Lifetime | 856 | CA 36 | 67.71 |
| Martial Arts: Techniques, Psychology, and Education | Lifetime | 954 | CA 22 | 47.17 |
| Poxvirus research and outbreaks | 2021-2025 | 3 | CA 1 | 99.21 |
| Sleep and related disorders | 2021-2025 | 15 | CA 2 | 99.17 |
| Bacillus and Francisella bacterial research | 2021-2025 | 10 | CA 1 | 98.04 |
| COVID-19 epidemiological studies | 2021-2025 | 70 | CA 3 | 98.52 |
| Herpesvirus Infections and Treatments | 2021-2025 | 25 | CA 1 | 97.75 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 516 | CA 11 | 97.88 |
| COVID-19 and Mental Health | 2021-2025 | 297 | CA 19 | 96.96 |
| Dietary Effects on Health | 2021-2025 | 29 | CA 1 | 95.90 |
| Sports injuries and prevention | 2021-2025 | 147 | CA 5 | 98.16 |
| Sports Performance and Training | 2021-2025 | 147 | CA 2 | 98.25 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 215 | CA 11 | 96.61 |
| COVID-19 and healthcare impacts | 2021-2025 | 312 | CA 19 | 94.66 |
| Cardiovascular and exercise physiology | 2021-2025 | 128 | CA 9 | 96.73 |
| Circadian rhythm and melatonin | 2021-2025 | 99 | CA 3 | 95.83 |
| Digital Mental Health Interventions | 2021-2025 | 142 | CA 4 | 95.76 |
| Artificial Intelligence in Healthcare and Education | 2021-2025 | 174 | CA 5 | 95.04 |
| Physical Activity and Health | 2021-2025 | 177 | CA 15 | 96.02 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 217 | CA 2 | 91.41 |
| COVID-19 Pandemic Impacts | 2021-2025 | 410 | CA 9 | 89.29 |
| Cardiovascular Effects of Exercise | 2021-2025 | 446 | CA 14 | 89.48 |
| Health and Lifestyle Studies | 2021-2025 | 323 | CA 4 | 87.72 |
| Sleep and Work-Related Fatigue | 2021-2025 | 194 | CA 7 | 86.90 |
| Exercise and Physiological Responses | 2021-2025 | 317 | CA 13 | 87.29 |
| Data-Driven Disease Surveillance | 2021-2025 | 168 | CA 3 | 84.56 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 517 | CA 20 | 88.94 |
| Global Health Care Issues | 2021-2025 | 602 | CA 10 | 82.61 |
| Global Public Health Policies and Epidemiology | 2021-2025 | 555 | CA 19 | 82.00 |
| Misinformation and Its Impacts | 2021-2025 | 593 | CA 15 | 86.27 |
| Animal Disease Management and Epidemiology | 2021-2025 | 855 | CA 29 | 84.41 |
| Virology and Viral Diseases | 2021-2025 | 445 | CA 17 | 78.00 |
| Healthcare cost, quality, practices | 2021-2025 | 558 | CA 53 | 77.63 |
| Healthcare Systems and Reforms | 2021-2025 | 765 | CA 18 | 78.56 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 779 | CA 20 | 80.29 |
| Sex and Gender in Healthcare | 2021-2025 | 146 | CA 21 | 78.73 |
| Children's Physical and Motor Development | 2021-2025 | 882 | CA 36 | 78.74 |
| Genetics and Physical Performance | 2021-2025 | 126 | CA 3 | 76.68 |
| Sport Psychology and Performance | 2021-2025 | 798 | CA 42 | 73.96 |
| Dermatological and COVID-19 studies | 2021-2025 | 328 | CA 5 | 68.06 |
| Optimism, Hope, and Well-being | 2021-2025 | 885 | CA 37 | 51.75 |
| Martial Arts: Techniques, Psychology, and Education | 2021-2025 | 238 | CA 4 | 42.50 |
| Mind wandering and attention | 2021-2025 | 541 | CA 39 | 42.66 |
| Gender Roles and Identity Studies | 2021-2025 | 957 | CA 79 | 34.67 |